21. Shareholders' Equity (Details Narrative) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 30, 2019 |
Mar. 31, 2018 |
Dec. 29, 2018 |
Dec. 30, 2017 |
|
| Common Stock, issued shares (in shares) | 1,695 | 1,695 | ||
| Common Stock, outstanding shares (in shares) | 1,695 | 1,695 | ||
| Options outstanding | 101 | 101 | 125 | |
| Share based compensation expense | $ 0 | $ 0 | ||
| Aggregate intrinsic value per share outstanding | $ 2.20 | |||
| Warrants outstanding | 33 | 33 | ||
| Warrant exercise price | $ 3.40 | $ 3.40 | ||
| Warrant expiration date | May 31, 2020 | |||
| Series A Preferred Stock [Member] | ||||
| Stock issued, Shares | 288,588 | |||
| 2016 Plan [Member] | ||||
| Options authorized for issuance | 400 | |||
| Options outstanding | 4 | 4 | ||
| 2011 Plan [Member] | ||||
| Options outstanding | 97 | 97 | ||
| Energy Efficiency Investments [Member] | ||||
| Warrants issued | 33 | |||
| Fair value of warrants issued | $ 106 | |||
| X | ||||||||||
- Definition Warrant expiration date No definition available.
|
| X | ||||||||||
- Definition Warrants issued No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares authorized for issuance under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|